Myosin inhibitor reverses hypertrophic cardiomyopathy in pediatric iPSC-cardiomyocytes to mirror variant correction

Kinnear, C.; Said, A.; Meng, G.; Zhao, Y.; Wang, E. Y.; Parmar, N.; Wei, W.; Billia, F.; Simmons, C. A.; Radisic, M.; Ellis, J.; Mital, S.

doi:10.1101/2023.04.14.536782

bioRxiv · 10.1101/2023.04.14.536782

Myosin inhibitor reverses hypertrophic cardiomyopathy in pediatric iPSC-cardiomyocytes to mirror variant correction

Kinnear, C.·Said, A.·Meng, G.·Zhao, Y.·Wang, E. Y.·Parmar, N.·Wei, W.·Billia, F.·Simmons, C. A.·Radisic, M.·Ellis, J.·Mital, S.

View original source ↗Export metadata ↓

Abstract

Hypertrophic cardiomyopathy (HCM) is mainly caused by sarcomere gene variants in MYH7 and MYBPC3. Targeted drugs like myosin ATPase inhibitors have shown efficacy in adult HCM but have not been evaluated in children. We generated iPSC-cardiomyocytes (CMs) from four children with HCM harboring variants in MYH7 (V606M; R453C) or MYBPC3 (G148R; P955fs and TNNI3_A157P), variant-corrected controls, and a healthy individual. All CMs showed hypertrophy and sarcomere disorganization. All 3 single variant CMs showed higher contractility, slower relaxation, higher calcium transients and higher ATPase activity. Only MYH7 variant CMs showed stronger myosin-actinin binding. Targeted myosin ATPase inhibitor showed complete rescue of the phenotype in affected CMs and in cardiac Biowires to mirror isogenic controls. The response was stronger compared to verapamil or metoprolol, highlighting the need for clinical trials of myosin targeted therapy in pediatric HCM patients. The phenotype and response to drug therapy are influenced by the underlying genotype.

Source connections

Published article ↗

Explore related subjects

genetics Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Kinnear, C., Said, A., Meng, G., Zhao, Y., Wang, E. Y., Parmar, N., Wei, W., Billia, F., Simmons, C. A., Radisic, M., Ellis, J., Mital, S.. 2023-04-14. Myosin inhibitor reverses hypertrophic cardiomyopathy in pediatric iPSC-cardiomyocytes to mirror variant correction. https://doi.org/10.1101/2023.04.14.536782

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Utilizing single-cell data for per-cell type eQTL mapping in the human pancreas

Aims/hypothesis The human pancreas is a central organ for metabolic regulation that is comprised of diverse cell types that uniquely contribute to its function. Previous studies have performed expression quantitative trail loci (eQTL) discovery in either whole pancreas or in pancreatic islets, but due to differences between pancreatic cell types, this approach does not reveal cell type-specific effects. In this study, we sought to either implicate the cell type of action for known eQTLs or identify new eQTLs that may have been masked in bulk studies by performing eQTL discovery in individual pancreatic cell types. Methods We clustered 153,018 single-cell RNA sequencing (scRNA-seq) data from 71 pancreatic islet donors from the Human Pancreas Analysis Program (HPAP). We performed eQTL discovery in six pancreatic cell types using this resource directly. We further utilized this single cell resource as a reference to deconvolute bulk pancreatic RNA sequencing data from 305 Genotype Tissue Expression (GTEx) project donors and performed eQTL discovery in four pancreatic cell types. Finally, we performed fine-mapping and co-localization of pancreatic cell type eQTLs with metabolic GWAS to connect our findings to metabolic disease risk. Results From analyzing 71 individuals with single cell profiles, we identified 112 unique eGenes across six pancreatic cell types, 99 of which had been identified previously and 13 unique to this study. From the deconvoluted eQTLs, we identified 3,134 unique eGenes across four pancreatic cell types, 116 of which were unique to our study. Fine-mapping and co-localization of eQTLs with metabolic GWAS yielded key leads that warrant further investigation, such as the association of rs2168101 with LMO1 expression in alpha cells. Conclusions/interpretation We identified new signals that were previously not found in bulk pancreatic eQTL studies and potential cell type of action for several signals that were identified previously. Although there are limitations to the power, and therefore, discoverability of this study, it provides insights into how individual pancreatic cells differently contribute to metabolic disease.

genetics↗

bioRxiv2026

Snurportin-1 maintains muscle niche integrity and myogenic progenitor homeostasis

Loss-of-function variants in SNUPN, encoding the nuclear import factor Snurportin-1 (SPN1) required for spliceosomal small nuclear ribonucleoprotein (snRNP) transport, cause a recently described form of limb-girdle muscular dystrophy (LGMD). However, the role of SPN1 in skeletal muscle homeostasis remains poorly understood, in part due to the lack of a suitable in vivo model. Here, we generated a zebrafish snupn loss-of-function model that recapitulates key features of the skeletal muscle phenotype observed in patients. Mutant larvae developed severe locomotor impairment by 6 days post-fertilization (dpf), accompanied by sarcomeric disorganization and impaired muscle fiber integrity. Transcriptomic profiling at 6 dpf revealed widespread alternative splicing and transcriptional dysregulation, with prominent alterations in extracellular matrix and basement membrane components, together with upregulation of stress- and inflammation-associated genes. Notably, these late-stage abnormalities were preceded by disruption of the muscle progenitor population at 2 dpf, with reduced Pax7 progenitor abundance and myogenic gene expression together with altered muscle differentiation and organization. Together, these findings identify SPN1 as a key regulator of skeletal muscle homeostasis linking RNA processing to extracellular niche integrity and myogenic progenitor maintenance. This zebrafish model provides an in vivo platform for dissecting LGMD-associated disease mechanisms and developing therapeutic strategies aimed at restoring muscle function and regenerative capacity.

genetics↗

bioRxiv2026

MOD-scTWAS: Leveraging gene co-expression for single-cell transcriptome-wide association studies

Transcriptome-wide association studies (TWAS) provide an effective framework for identifying genes associated with complex traits. Population-scale single-cell transcriptomic data enable genetically regulated expression (GReX) prediction and TWAS analyses at cell-type resolution, but the predictive performance of existing single-cell TWAS methods remains limited. Here, we develop MOD-scTWAS, a module-based method that jointly models GReX for genes within co-expression modules to borrow information across genes. Starting from a generative model for single-cell gene expression, MOD-scTWAS accounts for the heteroscedasticity and cross-gene correlation of individual-level pseudobulk expression in joint GReX prediction. In cross-validation analyses of the OneK1K dataset, MOD-scTWAS achieved higher mean GReX prediction accuracy than scTWAS across all 14 cell types and increased the number of imputable genes. When applied to TWAS analyses of UK Biobank quantitative hematological traits, MOD-scTWAS identified more significant cell type-gene-trait associations than scTWAS. These results demonstrate the potential of leveraging gene co-expression through joint modeling to improve cell-type-specific GReX prediction and TWAS discovery.

genetics↗